Pharma AI Adoption Hobbled by Employee Engagement Gaps
Event summary
- 94% of pharma quality leaders cite poor employee adoption of quality systems as a major hurdle for AI integration, compared to 83% in biotech.
- 86% of pharma leaders report AI is meeting or exceeding expectations, but 25% highlight data privacy as the top implementation challenge.
- 43% of pharma leaders prioritize quality defect prediction as AI's most valuable use case.
- 79% of pharma manufacturing leaders still rely on manual, inefficient processes.
- Only 17% of pharma organizations have deployed Real-time Location Systems (RTLS), a key gap for AI infrastructure.
The big picture
Pharma leaders are optimistic about AI but face foundational challenges in employee engagement and system integration. The industry's success with AI will depend on resolving these human and technical gaps, particularly as manual processes remain widespread in manufacturing. The strategic priority is clear: AI is only as powerful as the systems it connects to, making unified quality and manufacturing platforms a critical investment.
What we're watching
- Integration Challenges
- Whether pharma companies can resolve system integration gaps to fully leverage AI capabilities.
- Employee Engagement
- How pharma organizations will address low adoption rates of quality systems critical for AI success.
- Regulatory Compliance
- The impact of data privacy concerns on AI deployment in highly regulated pharmaceutical environments.
Related topics